TickerGuard
Buy Day today: Poor (44) Weak market breadth · major macro event coming up
PEN

Penumbra Inc

Healthcare · Medical Devices

319.40$ +0.0% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Cash Flow

All figures as a percentage of revenue in the same period.

Tick rows to compare them in a chart (up to 4)

Cash Flow PEN
Line item 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
-5.1% -12.0% -4.9% 3.8% 6.5% 4.9% -5.9% 1.3% -6.6% 9.2% 14.1% 17.0%
0.6% 0.9% 0.9% 1.1% 1.4% 1.4% 2.3% 2.6% 3.3% 2.9% 2.0% 1.2%
1.1% 3.9% 5.6% 5.3% 4.1% 3.9% 4.6% 8.8% 4.4% 4.8% 3.9% 4.2%
2.2% 3.2% 2.4% 5.3% 4.3% -5.2% 4.3% 7.6% 5.1%
-9.6% -17.3% -13.7% -4.0% -6.8% -10.4% -9.1% -8.9% -14.3% -7.5% -2.0% -3.0%
3.1% 2.9% 5.2% 4.5% 2.2% 4.0% 4.4% 2.8% 2.3% 1.4% 1.8% 4.5%
-29.5% -46.1% 0.3% -23.3% -0.1% -2.2% -18.6% -2.9% 6.5% -1.5% 6.5% -28.8%
0.0% 0.0% 0.0% 3.4% 1.8% 2.1% 0.9%
-7.5% -1.4% -1.0% -3.5% -4.0% -3.4% -1.8% -2.1% -0.9% -0.2% -8.4% 2.3%
-4.8% -0.6% -0.4% -0.3% -0.1% -0.5% -0.6% -0.2% -0.2% -0.2% -0.2% -0.2%
34.2% 66.9% 2.7% 31.3% -2.2% -1.8% 24.1% 0.1% 1.4% 1.5% -7.3% 1.9%
-0.7% 8.7% -2.4% 11.2% 3.9% 0.9% -0.6% -1.4% 1.2% 9.2% 13.1% -9.8%
-8.2% -14.9% -10.0% -0.7% 4.3% 0.8% -10.3% -1.6% -8.8% 7.8% 12.3% 12.5%

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?